Fourth day to the knowledge of the night Paroxistica Hemoglobinuria (HPN) held in Barcelonas Hospital ClÃnic.
Fourth day for the knowledge of the night Paroxistica Hemoglobinuria (HPN) held in Barcelona’s Hospital ClÃnic. -la HPN is ultra-raras few diseases with a treatment that allows the patient to have the same rates of survival than the general population Barcelona, July 2012.- diagnosis of a patient with paroxysmal Paroxistica night (HPN) may take up to 10 years, a fact that causes a delay in the treatment of disease, as they have highlighted the specialists gathered in the sixth day to the knowledge of the HPN ” held at the Hospital ClÃnic of Barcelona. Paroxysmal nocturnal hemoglobinuria (PNH) is a ultra-rara disease that affects about 250 people in Spain and that is characterized by the destruction of red blood cells (hemolysis) and can cause thrombosis, main cause of death among these patients. It’s one of the few ultra-raras diseases with treatment showing same rates of survival than the general population. Hence, according to experts, it is so important to properly diagnose this type of disease so rare and subsequently manage the treatment. Flow cytometry is one of the methods to diagnose the HPN, but it can take years to request the test, so explained Dr. Neus Villamor, Senior Consultant of the Centre for biomedical diagnosis of the Hospital ClÃnic of Barcelona. The Paroxistica nocturnal Hemoglobinuria is ultra-raras few diseases with a treatment that allows the patient to have the...
Read More